OPDIVO® (nivolumab) is a prescription medicine used to treat people with a type of advanced numerous cancers. most use of Opdivo is advised in below situations:
For certain adults with advanced non-small cell lung cancer (NSCLC): OPDIVO® (nivolumab) is a prescription medicine used in combination with YERVOY® (ipilimumab) as a first treatment for adults with a type of advanced stage lung cancer (called non-small cell lung cancer).
For people with previously treated advanced non-small cell lung cancer.
For people with advanced melanoma
For people with melanoma after it and the affected lymph nodes have been removed by surgery to prevent it from coming back
For certain people with advanced kidney cancer (renal cell carcinoma)
For newly diagnosed adults whose kidney cancer (renal cell carcinoma) has spread
For people with previously treated advanced kidney cancer (renal cell carcinoma)
For people with previously treated squamous cell carcinoma of the head and neck